Growth Metrics

Enovis (ENOV) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn 68.80%

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 68.80%
Dec 31, 2025 -487.56%
Oct 3, 2025 -101.78%
Jul 4, 2025 -36.76%
Dec 31, 2024 3,450.00%
Sep 27, 2024 -86.50%
Jun 28, 2024 -101.42%
Dec 31, 2023 -99.93%
Sep 29, 2023 3,251.99%
Jun 30, 2023 110.99%
Mar 31, 2023 -102.07%
Dec 31, 2022 14.77%
Sep 30, 2022 -102.04%
Jul 1, 2022 -252.45%
Apr 1, 2022 -21.00%
Dec 31, 2021 127.31%
Oct 1, 2021 92.81%
Jul 2, 2021 438.00%
Apr 2, 2021 325.66%
Dec 31, 2020 47.02%
Oct 2, 2020 27.99%
Jul 3, 2020 98.19%
Apr 3, 2020 108.61%
Dec 31, 2019 49.86%
Sep 27, 2019 -43.52%
Jun 28, 2019 -7,638.03%
Mar 29, 2019 -728.15%
Dec 31, 2018 -694.35%
Sep 28, 2018 790.68%
Jun 29, 2018 96.85%
Mar 30, 2018 104.18%
Dec 31, 2017 -165.11%
Sep 29, 2017 -92.56%
Jun 30, 2017 -584.69%
Mar 31, 2017 -975.30%
Dec 31, 2016 -14.54%
Sep 30, 2016 52.35%
Jul 1, 2016 -25.17%
Apr 1, 2016 -56.56%
Dec 31, 2015 -44.85%
Sep 25, 2015 -74.98%
Jun 26, 2015 -72.30%
Mar 27, 2015 109.25%
Dec 31, 2014 150.54%
Sep 26, 2014 45.64%
Jun 27, 2014 259.78%
Mar 28, 2014 10.30%
Dec 31, 2013 118.11%
Sep 27, 2013 1,152.83%
Jun 28, 2013 630.92%
Mar 29, 2013 120.63%
Dec 31, 2012 191.19%
Sep 28, 2012 9.00%
Jun 29, 2012 -29.81%
Mar 30, 2012 -1,767.92%
Dec 31, 2011 -285.90%
Sep 30, 2011 -36.93%
Jul 1, 2011 397.61%